A prospective, double-blind, randomised controlled trial comparing oral versus intravenous tranexamic acid for blood loss reduction in primary total knee arthroplasty.

PURPOSE: Total knee arthroplasty (TKA) is associated with significant perioperative blood loss. While intravenous tranexamic acid (TXA) effectively reduces bleeding, oral TXA may offer comparable efficacy with economic and logistical advantages. We a…

Preview only. Read the full abstract at the source